Alliancebernstein L.P. Xencor Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Xencor Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 75,250 shares of XNCR stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,250

Previous 75,250 -0.0%

Holding current value

$1.82 Million

Previous $1.42 Million 6.25%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$18.65 - $26.52 $45,692 - $64,974	-2,450 Reduced 3.15%	75,250 $1.67 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $77,308 - $97,751	-3,850 Reduced 4.72%	77,700 $1.57 Million
Q1 2023 May 15, 2023	SELL	$25.95 - $36.95 $129,594 - $184,528	-4,994 Reduced 5.77%	81,550 $2.27 Million
Q4 2022 Feb 14, 2023	SELL	$24.79 - $30.86 $122,065 - $151,954	-4,924 Reduced 5.38%	86,544 $2.25 Million
Q3 2022 Nov 15, 2022	BUY	$24.62 - $32.44 $2,462 - $3,244	100 Added 0.11%	91,468 $2.38 Million
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $70,373 - $103,420	-3,565 Reduced 3.76%	91,368 $2.5 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $7,577 - $11,822	284 Added 0.3%	94,933 $2.53 Million
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $5,185 - $6,689	154 Added 0.16%	94,649 $3.8 Million
Q3 2021 Nov 10, 2021	SELL	$30.65 - $35.68 $83,981 - $97,763	-2,740 Reduced 2.82%	94,495 $3.09 Million
Q2 2021 Jul 30, 2021	BUY	$34.33 - $44.68 $120,498 - $156,826	3,510 Added 3.74%	97,235 $3.35 Million
Q1 2021 May 06, 2021	BUY	$40.81 - $53.88 $46,931 - $61,962	1,150 Added 1.24%	93,725 $4.04 Million
Q3 2020 Nov 12, 2020	BUY	$30.09 - $43.02 $48,444 - $69,262	1,610 Added 1.77%	92,575 $3.59 Million
Q2 2020 Aug 13, 2020	BUY	$27.76 - $33.42 $194,042 - $233,605	6,990 Added 8.32%	90,965 $2.95 Million
Q1 2020 May 14, 2020	BUY	$20.69 - $37.79 $2,069 - $3,779	100 Added 0.12%	83,975 $2.51 Million
Q4 2019 Feb 18, 2020	BUY	$32.75 - $41.43 $9,825 - $12,429	300 Added 0.36%	83,875 $2.88 Million
Q3 2019 Nov 14, 2019	BUY	$33.73 - $46.27 $299,353 - $410,646	8,875 Added 11.88%	83,575 $2.82 Million
Q2 2019 Aug 14, 2019	BUY	$29.6 - $40.93 $281,200 - $388,835	9,500 Added 14.57%	74,700 $3.06 Million
Q4 2018 Feb 13, 2019	SELL	$32.39 - $42.05 $16,195 - $21,025	-500 Reduced 0.76%	65,200 $2.36 Million
Q2 2018 Aug 13, 2018	BUY	$28.41 - $42.41 $468,765 - $699,765	16,500 Added 33.54%	65,700 $2.43 Million
Q1 2018 May 14, 2018	BUY	$21.18 - $33.78 $36,006 - $57,426	1,700 Added 3.58%	49,200 $1.48 Million
Q4 2017 Feb 13, 2018	SELL	$19.29 - $24.83 $55,941 - $72,007	-2,900 Reduced 5.75%	47,500 $1.04 Million
Q3 2017 Nov 13, 2017	BUY	$19.61 - $23.35 $988,344 - $1.18 Million	50,400	50,400 $1.16 Million

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Xencor Inc Transaction History